LAVA Therapeutics (LVTX)
(Delayed Data from NSDQ)
$1.63 USD
0.00 (0.00%)
Updated Sep 23, 2024 03:59 PM ET
After-Market: $1.66 +0.03 (1.84%) 7:06 PM ET
4-Sell of 5 4
D Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/21/24 |
---|---|
Current Quarter | -0.35 |
EPS Last Quarter | -0.31 |
Last EPS Surprise | 6.06% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.28 |
Next Year | -1.55 |
EPS (TTM) | -0.91 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 7.00M | NA |
# of Estimates | NA | NA | 1 | NA |
High Estimate | NA | NA | 7.00M | NA |
Low Estimate | NA | NA | 7.00M | NA |
Year ago Sales | 0.05M | 0.35M | 6.77M | 7.00M |
Year over Year Growth Est. | NA | NA | 3.41% | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.35 | -0.30 | -1.28 | -1.55 |
# of Estimates | 2 | 2 | 3 | 2 |
Most Recent Consensus | -0.39 | -0.41 | -1.43 | -1.47 |
High Estimate | -0.30 | -0.19 | -1.20 | -1.47 |
Low Estimate | -0.39 | -0.41 | -1.43 | -1.62 |
Year ago EPS | -0.34 | -0.24 | -1.57 | -1.28 |
Year over Year Growth Est. | -2.94% | -25.00% | 18.47% | -20.70% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.35 | -0.30 | -1.28 | -1.55 |
7 Days Ago | -0.35 | -0.30 | -1.28 | -1.55 |
30 Days Ago | -0.35 | -0.30 | -1.28 | -1.55 |
60 Days Ago | -0.34 | -0.29 | -1.27 | -1.53 |
90 Days Ago | -0.35 | -0.30 | -1.30 | -1.56 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.35 | -0.30 | -1.28 | -1.55 |
Zacks Consensus Estimate | -0.35 | -0.30 | -1.28 | -1.55 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.31 | -0.02 | -0.24 | -0.34 | NA |
Estimate | -0.33 | -0.25 | 0.16 | -0.48 | NA |
Difference | 0.02 | 0.23 | -0.40 | 0.14 | 0.00 |
Surprise | 6.06% | 92.00% | -250.00% | 29.17% | -30.69% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more